
Lewis Hong
VP, Discovery Research and Site Head Singapore
Lewis has over a decade of experience in biopharma working in discovery research and translational sciences. At Paratus Sciences, Lewis oversees operations and R&D strategy at the Singapore site and serves as Discovery lead for Inflammation and Immunology (I&I), supporting target identification through to IND-enabling studies. Most recently, Lewis was Director of Biomarker and Target Sciences at MSD Singapore (known as Merck in the US and Canada), where he helped to establish a Translational Oncology research hub and led a team that supported target identification and preclinical/clinical biomarker projects across multiple therapeutic areas.
Lewis holds a Bachelor of Science degree from the University of Wisconsin – Madison and a Ph.D. in Genetics from Stanford University.